|
Contact the ACC Registration and Housing Center |
Innovation Stage
Expo, #2064
The ACC.26 Innovation Stage is a unique theater that provides an opportunity to enjoy a 30-minute focused discussion in a relaxed setting.
Quick Links: Saturday, March 28 • Sunday, March 29 • Monday, March 30
Saturday, March 28
9:45 – 10:15 a.m.
4201. Accelerating Cardiac Amyloidosis Diagnosis With AI-Assisted ECG and Imaging: Implementation Insights From Mayo Clinic
Innovation Stage, #2064
Sponsored by AstraZeneca
Speaker:
Patricia A. Pellikka, MD
Mayo Clinic
Rochester, MN
10:45 – 11:15 a.m.
4202. She Says/He Says: HFrEF Patient Management in the Contemporary Era of GDMT: A Friendly Debate
Innovation Stage, #2064
Sponsored by ZOLL
In this sure-to-be lively session, Dr. Hrobowski-Blackman, an advanced heart failure and transplant cardiologist, and Dr. Tomassoni, an electrophysiologist, will debate approaches to managing HFrEF patients, to include recent data on sudden cardiac arrest risk.
Speakers:
Tara Hrobowski-Blackman, MD
HCA Florida Largo Hospital
Largo, FL
Gery Tomassoni, MD, FACC, FHRS
Baptist Health Lexington
Lexington, KY
11:45 a.m. – 12:15 p.m.
4203. Title to be Announced
Innovation Stage, #2064
Sponsored by Bristol Myers Squibb
1 – 1:30 p.m.
4204. A Clinician's Perspective: Holistic Approach to Managing PKP2-Associated Arrhythmogenic Cardiomyopathy
Innovation Stage, #2064
Sponsored by Lexeo Therapeutics
2:30 – 3 p.m.
4205. AI-driven echocardiography: From insight to impact
Innovation Stage, #2064
Sponsored by Siemens Healthineers
Sunday, March 29
9:30 – 10 a.m.
4206. Title to be Announced
Innovation Stage, #2064
Sponsored by ZOLL
11:45 a.m. – 12:15 p.m.
4207. The Future of TAVR & Evolut in Low-Risk Patients
Innovation Stage, #2064
Sponsored by Medtronic
Evolut demonstrates a sustained commitment to clinical innovation by addressing the increasingly complex and evolving requirements of valve selection for patients undergoing TAVR. Explore clinical insights on the use of Evolut TAVR in low-risk patients and examine how AI-driven pre-procedural planning can enhance procedural decision-making.
1:15 – 1:45 p.m.
4208. On ALERT: Using AI-Powered EHR Alerts to Fast Track Evidence Based Care For VHD
Innovation Stage, #2064
Sponsored by Medtronic
3 – 3:30 p.m.
4209. Decoding a Silent Threat: Uncovering Aldosterone's Impact on Hypertension and Cardiovascular Morbidity
Innovation Stage, #2064
Sponsored by AstraZeneca
Monday, March 30
10 – 10:30 a.m.
4210. Title to be Announced
Innovation Stage, #2064
Sponsored by Heartflow
11:45 a.m. – 12:15 p.m.
4211. Treating Hyperkalemia: A Critical Step in Heart Failure Management
Innovation Stage, #2064
Sponsored by AstraZeneca
Innovation Stage presentations are not part of ACC.26, as planned by its Program Committee, and do not qualify for continuing medical education (CME), continuing nursing education (CNE) or continuing education (CE) credit.
*Information as of Jan. 22, 2026.
© 2025 American College of Cardiology Foundation. Visit ACC.org
Terms and Conditions • Registered User Agreement • Advertising and Sponsorship Policy • Privacy Policy • Cookie Policy • Contact Us